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ABSTRACT: Leucorrhoea and dysfimctional uterine bleeding are very common and significant 
clinical manifestations seen by the gynecologist in their day-to day practice and these complaints 
are sufficient to create distress in females. Lukol has shown efficacy in symptomatic relief in 
these conditions. A total of sixty cases were registered after a complete detailed investigation. 
Lukol 2 tablets thrice a day were administered and reviewed after 15 days.  The response 
assessed on the basis of symptomatic improvement. 
 
INTRODUCTION 
 
Among various gynaecological disorders 
leucorrhoea, pelvic inflammatory diseases 
(PID) and dysfunctional uterine bleeding 
(DUB) are very common conditions.   
Thought these are quite different diseases 
yet, mostly all respond to astringent, anti-
inflammatory and styptic drugs, correcting 
the metabolic processes in the body. 
 
Vulvovaginitis is generally considered to be 
the most common gynaecological problem 
in premenarchal girls, although the actual 
incidence is unknown.  Several factors are 
said to contribute to inflammation of the 
genital area.  These include relatively less 
protective covering of the introitus by the 
labia majora, low oestrogen concentrations 
leaving the vaginal mucosa susceptible to 
irritants (Such as bubble bath), poor 
hygiene, and infection by specific 
pathogens1.  Researchers in previous study 
have shown that the last two factors were 
common in causing vaginitis
2,3 Leucorrhoea 
is characterized with painless white 
discharge per vaginum and is a symptom of 
many underlying diseases.  The aetiology 
includes excessive coitus
4-7 abortions, non 
cleanliness, improper diet, constipation 
besides cervical erosion and PID etc. 
 
The infection of cervix, corpus, fallopian 
tubes, ovaries, parametrium and pelvic 
peritoneum is clinically termed as pelvic 
inflammatory disease.  The aetiology 
includes pyogenic, gram positive and 
negative bacteria, tubercular and syphilitic 
organisms, parasitic fungal or other 
infections Due to relatively less blood 
supply, and lack of oral or parenteral drugs, 
PID turns chronic, characterized by 
mucopurulent vaginal discharge, backache, 
fever and pain in lower abdomen~’’’. 
 
Irregular, excessive or prolonged menstrual 
bleeding without demonstrable pathology is 
termed as dysfunctional uterine bleeding. 
Change in the rhythm of hormonal secretion 
and emotional disturbances leading to 
abnormal pituitary secretions as a result of 
altered hypothalamic signals lead to 
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DUB
7,8,10 Thus, no significant abnormally is 
found in the ovarian and endometrial 
pictures except abnormal pelvic congestion. 
 
MATERIALS AND METHODS 
 
A Clinical trial was conducted in patients to 
evaluate the efficacy of Lukol in leucorrhoea 
DUB and symptoms of pelvic inflammatory 
disease. 
 
Criteria of Inclusion of Patients 
 
1.  Women with leucorrhoea m the age 
group of 25-55 years. 
2.  Women dysfunctional uterine 
bleeding from puberty to 
premenopause. 
3.  Women with symptoms of pelvic 
inflammatory  disease in 
reproductive age group of 20-35 
years. 
 
Criteria of Exclusion of Patients 
 
1.  Pregnancy 
2.  Patients with psychosis and organic 
brain damage 
3.  Any organic pathology of 
reproductive or other system 
4.  Severe hepatic, cardiac or renal 
diseases, diabetes mellitus. 
 
Sixty females with the above  criteria were 
registered for the study. In these cases age, 
parity, chief complaints with duration, 
detailed menstrual and obstetric history were 
recorded and complete general, systemic and 
gynaecological examinations were done.  
 
In the first visit when women were 
registered for leucorrhoea, PID and DUB 
few investigations like blood for TLC, DLC, 
Hb% etc. and urine for routine and 
microscopic examinations were advised. If 
all these investigations were normal and 
there was no other systemic disease or any 
recognizable organic pathology only then 
were they selected for the study.  All the 
patients were advised Lukol tablet at a dose 
of 2 tablets, three times daily for 15 days.  
The duration of treatment was in accordance 
to the relief in symptoms, however, DUB 
cases were given the drugs for there 
consecutive months, All the cases were 
followed for nightly for 6 months.  The 
results were assessed on the basis of 
symptomatic improvements. 
 
OBSERVATIONS, RESULTS AND 
DISCUSSION 
 
As the conditions taken for study are the 
ailments mostly of a active reproductive age, 
majority of cases were in the age group of 
20-30 years, however maximum cases I the 
deferent disease groups were between the 
age group of 20- 25,30-35 and 20-30 years 
in leucorrhoea, PID and DUB. 
 
Twelve women were nulliparous and others 
had 1-3 children. NuUiparity and only one 
child were the common findings in 
leucorrhoea and PID, while multiparity was 
the common finding of DUB (Table 1). 
 
Maximum cases in all the disease were 
housewives coining from lower or middle 
class, however, In DUB upper and middle 
service class women dominated (Table 2). 
 
In women suffering from leucorrhoea and 
PID maximum frequency of sexual 
intercourse was observed to be daily 
followed by alternate day, while in DUB 
cases frequency was once or twice in a 
month, probably because of marked ill 
health or more duration of bleeding period. 
 
Hygienic status appears to be directly related 
to socio –economic status as it was observed 
that patients having leucorrhoea and PID 
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had poor hygienic status, while DUB was 
found in women observing average hygiene. 
 
Women consuming non-vegetarian food 
were more in leucorrhoea and DUB, while 
vegetarian women were more in PID, which 
could be due to relatively small sample size 
 
Vaginal discharge with pain and itching in 
vulva and vagina and painful coitus were the 
chief complaints among patients with 
Ieucorrhoea while vaginal discharge, pain in 
lower abdomen, backache, pain during 
menstruation and irregular menstruation 
were the common complaints of PID cases. 
Women with DUB were suffering from 
excessive bleeding, early periods, weakness 
and palpitation, Almost all cases registered 
for leucorrhoea had normal intermenstrual 
period, normal duration of menstrual 
bleeding except 1 (5% had only one day 
bleeding ), had normal amount and 
consistency of menstrual blood except 5 
(L25% scanty and thin blood loss). In PID 
group, 12 cases had shorter intermenstrual 
period, 95% had normal amount and 
consistency (25% had scanty thin blood 
loss). 
 
In DUB group menstrual abnormality in all 
the parameters of observation was seen in 
most of the cases as shown in Table3. 
 
In less and moderate bleeding, pain was 
common finding in the PID and Dub 
patients. 
 
Patients suffering from leucorrhoea had no 
pain before or during menstruction (Table 
4). 
 
Maximum leucorrhoea cases had moderate, 
thin or thick curdy, whitish or yellowish 
vaginal discharge with no smell.  In DUB 
cases only 5 (25%) cases had mild, thin, 
whitish vaginal discharge with no smell.  In 
the women who suffered from PID vaginal 
discharge was seen to be moderate in 
amount, mucopurulent, yellowish or whitish 
with obnoxious smell (Table 5). 
 
Most of the leucorrhoea and DUB cases had 
normal vulva, vagina and cervix, uterus size, 
anteverted uterus and up-right uterus, freely 
mobile with non-tender fomices, while in 
PID cases most common findings were 
vulva, vagina and cervix congested, uterus 
was retroverted normal in size, restricted 
mobility with tender fornics (Table 6). 
 
None of the cases registered had any other 
abnormality of reproductive and other 
system.  All the cases were given Lukol 
tablets. 
 
Great variation of improvement in specific 
symptom was seen in all the three disease 
groups.  Leucorrhoea cases reported 
improvement within 7-10 days after 
treatment and complete recovery within one 
–month period. 
 
Improvement in PID cases was slightly 
delayed, which started during second follow 
up, i.e. after 30 days, however, total relief 
was reported after 45 days. 
 
As improvement in DUB cases cannot be 
seen before onset of next cycle, relief was 
noted only after one month and complete 
recovery after three months in most of the 
cases. 
 
Corresponding to improvement in principle 
diseases associated symptoms also diseases 
associated symptoms also showed 
improvement. HP% also increased. 
 
No recurrence was seen within the period of 
follow-up, i.e six months. Maximum 
improvement in cases of leucorrhoea, PID 
and DUB was respectively noted within one, 
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two and three months. Continuation of 
further treatment showed no change. 
 
Lukol consists of 25 ingredients, Table: 0 
which include Trivanga and Loh bhasma 
metallic Preparation.  Out of herbal drugs 
good number have Tikta and Kashay rasa. 
Laghu and Ruksha guna, Ushnavirya and 
Katu Vipaka.  All these properties suppress 
Kapha and normalize Pachakagni (digestive 
fire) thereby Dhatvagni (cellular 
metabolism), beside Kashayarasa is also 
astringent. Guggulu, Trivanga are shothagna 
or anti inflammatory, Kaphagna property 
couplet with anti-inflammatory and 
appetising properties of the drugs might 
have been responsible for normalization of 
aggravated kapha. 
 
In majority of the cases of PID some 
irregularity of menstruation is seen. Guggulu 
is artavajanana drug.  The inflammation of 
any part is due to vitiation of Pitta, since 
some of the drugs have katu Vipaka which 
propertises increased pitta, while others of 
Kasaya, Tikta, Madhura rasa.  Sheet virya, 
madhur Vipaka suppress the pita. Due to 
these mixed properties of constituent’s very 
good effect of PID were not observed, 
however anti-inflammatory property of 
triphala. Trivanga and  guggulu did dive 
efficacy in some cases. 
 
In comparison to the PID cases better cure in 
DUB is noted. Though hypothetically 
reasons discussed under PID have operated 
thus amount of bleeding should have 
increased, however strong kashay and 
Rakta-stambhaka properties of Dhatki, 
Nagkeshara, etc., drugs along with Tirvanga, 
Loh bhasma reduced the amount of bleeding 
hence improvement in DUB is noted.  It 
appears that the drugs acted most by its 
prabhave.  In summarizing it can be said that 
beneficial effect of Lukol is probably due to 
anti-inflammatory, astringent, appetizing 
properties of different drugs, better appetite 
and disestion with regular bowel movement, 
improve general health besides 
psychological satisfaction also might have 
helped in pelvic congestion. 
 
CONCLUSION  
 
1.  Lukol is very effective drug in 
lecorrhoea. 
 
2.  Lukol gives good results in DUB cases. 
 
3.  The efficacy of Lukol in PID cases need 
further study. 
 
4.  In overall observation the drug Lukol 
seen to be mild anti-inflamatory, 
astringent, appetizer, it improves general 
health and feeling of well-being thus 
better efficacy in leucorrhoea and DUB 
cases. 
 
5.  With regard to PID unsatisfactory 
response may be due to less anti-
inflamatory property and negligible 
antibacterial effects. 
 
Table 1: Showing age and parity incidence 
   
Age 
In 
years 
Total 
cases 
(n=60) 
No. (%) 
Leuco-
rrhoea 
(n=20) 
No(%) 
PID 
(n=20) 
N0.(%)
DUB 
(n=20)
no(%) 
Parity 
in No 
(n=60)
Total 
cases 
(n=60) 
No.(%) 
Leuco-
rrhoea 
(n=20) 
No(%) 
PID 
(n=20) 
N0.(%) 
DUB 
(n=20)
no(%) 
15-20 
20-25 
7(11.67) 
17(28.33) 
2(10) 
10(50) 
4(20) 
1(5) 
1(5) 
6(30) 
0 
1 
12(20) 
18(30) 
6(30) 
9(45) 
4(20) 
8(40) 
2(10) 
1(5) 
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25-30 
30-35 
35-40 
Above 
40 
12(20) 
15(25) 
6(10) 
3(5) 
2(20) 
4(20) 
2(10) 
1(5) 
9(45) 
3(15) 
2(10) 
9(45) 
2(10) 
1(5) 
1(5) 
2 
3 
4 
Above 
4 
12(20) 
9(15) 
7(11.67)
2(3.33) 
2(10) 
1(5) 
1(5) 
1(5) 
5(25) 
2(10) 
1(5) 
5(25) 
6(30) 
5(25) 
1(5) 
 
PID: Pelvic Inflammatory Diseases 
DUB: Dysfunctional Uterine Bleeding 
 
Table-2: Showing socio – economic and occupational status 
  
Socio-
economic 
status  
Total 
cases 
(n=60) 
No.(%) 
Leuco-
rrhoea 
(n=20) 
No(%) 
PID 
(n=20) 
N0.(%)
DUB 
(n=20)
no(%) 
Ocupa 
tional 
status 
Total 
cases 
(n=60) 
No.(%) 
Leuco-
rrhoea 
(n=20) 
No(%) 
PID 
(n=20) 
N0.(%)
DUB 
(n=20)
no(%) 
High 
class 
Middle 
class 
Low 
class 
14(23.33) 
 
24(40) 
 
22(36.67) 
3(15) 
 
10(50) 
 
7(35) 
3(15) 
 
7(35) 
 
10(50) 
 
8(40) 
 
7(35) 
 
5(25) 
 
 
House 
Wife 
Service
 
 
40(66.67)
 
20(33.33)
18(90) 
 
2(10) 
 
17(85) 
 
3(15) 
5(25) 
 
15(75) 
 
Table 3: Showing intermenstrual period durational of bleeding 
        
Inter-
menstrual 
period in 
days 
Total 
cases 
(n=60) 
No.(%) 
Leuco-
rrhoea 
(n=20) 
No(%) 
PID 
(n=20) 
N0.(%)
DUB 
(n=20)
no(%) 
Duration 
of 
bleeding 
Total 
cases 
(n=60) 
No.(%) 
Leuco-
rrhoea 
(n=20) 
No(%) 
PID 
(n=20) 
N0.(%)
DUB 
(n=20)
no(%) 
20-21 
24-28 
30-35 
19(31.60) 
36(60.00) 
5(8.33) 
- 
18(90) 
2(10) 
12(60) 
6(30) 
2(10) 
7(35) 
12(60) 
1(5) 
0-1 
1-3 
3-5 
5-8 
2(3.33) 
26(43.33)
20(33.33)
12(20.00)
1(5) 
12(60) 
5(25) 
2(10) 
1(5) 
11(55) 
8(40) 
- 
- 
3(15) 
7(35) 
10(50)
 
Table 4: Showing amount and consistency of menstrual bleeding 
 
Amount 
of 
menstrual 
bleeding 
Total 
cases 
(n=60) 
No.(%) 
Leuco-
rrhoea 
(n=20) 
No(%) 
PID 
(n=20) 
N0.(%)
DUB 
(n=20)
no(%) 
Consiste
ncy of 
menstru
al 
bleeding 
Total 
cases 
(n=60) 
No.(%) 
Leuco-
rrhoea 
(n=20) 
No(%) 
PID 
(n=20) 
N0.(%)
DUB 
(n=20)
no(%) 
Scanty 
 
Normal 
 
Excessive 
11(18.33)
 
27(45) 
 
22(36.66)
5(25) 
 
15(75) 
 
- 
6(30) 
 
10(50) 
 
4(20) 
- 
 
2(10) 
 
18(90) 
Thin  
 
Normal  
 
Clotted  
11(18.33) 
 
30(50) 
 
19(31.66) 
5(25) 
 
15(75) 
 
- 
6(30) 
 
10(50) 
 
4(20) 
- 
 
5(25) 
 
15(75) 
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Table-5: Showing amount and consistency of menstrual bleeding along with severity of pain 
 
Severity of pain  Total  cases 
(n=60) 
No.(%) 
Leuco-
rrhoea 
(n=20) 
No(%) 
PID 
(n=20) 
N0.(%) 
DUB 
(n=20) 
no(%) 
Premenstrual: 
a) Mild 
 
b) Moderate 
 
c) Severe 
 
Menstrual: 
a) Mild 
 
b) Moderate 
 
c) Severe 
 
Without pain 
 
 
6(10) 
 
3(5) 
 
1(1.67) 
 
 
10(16.67) 
 
11(18.33) 
 
5(8.3) 
 
24(40) 
 
1(5) 
 
- 
 
- 
 
 
1(5) 
 
- 
 
- 
 
18(90) 
 
3(15) 
 
210 
 
15 
 
 
525 
 
630 
 
315 
 
- 
 
2(10) 
 
1(5) 
 
- 
 
 
4(20) 
 
5(25) 
 
2(10) 
 
6(30) 
 
 
Table-6: Showing amount and character of vaginal discharge 
 
Character of vaginal discharage   Leucorrhoea (n=20) 
No(%) 
PID (n=20) 
No(%) 
Amount: 
a)Mild 
b)Moderate 
c)Sever 
 
3(15) 
10(50) 
7(35) 
 
6(30) 
13(65) 
1(5) 
Consistency: 
a)Thick curdy 
b)Mucopurulent 
c)Thin 
 
8(40) 
- 
12(60) 
 
6(30) 
10(50) 
4(20) 
Smell: 
a) No smell 
b) Abnoxious 
 
12(60) 
8(40) 
 
4(20) 
16(80) 
Colour: 
a)Whitish 
b)Yellowish 
c)Pinkish 
 
11(55) 
8(40) 
1(5) 
 
8(40) 
10(50) 
2(10) 
 
 
 
 
 
pages 139 - 149  7
Table 7 : Showing finding of P/S and P/V examination 
 
P/S and P/V 
findings 
No.of 
Patients 
Leucorrhoea 
% 
No.of 
Patients 
PID %  No.of 
Patients 
DUB % 
Vulva and Vagin: 
a) Normal 
b) Congested 
 
12 
8 
 
60 
40 
 
18 
2 
 
90 
10 
 
19 
1 
 
95 
5 
Cervix: 
a) Normal 
b) Congested 
 
12 
8 
 
60 
40 
 
2 
18 
 
10 
90 
 
17 
3 
 
85 
15 
Uterus: 
a) Normal size 
b) Subnormal size 
c) Slightly bigger 
 
14 
6 
- 
 
70 
30 
- 
 
16 
- 
4 
 
80 
- 
20 
 
15 
- 
5 
 
75 
- 
25 
A.V.  8  40  10 50 6  30 
R.V.  5 25  4 20  2  10 
Up-right  7 35  6 30  12  60 
Uterus mobility: 
a)Freely mobile 
b)Restricted 
mobility  
 
19 
1 
 
95 
5 
 
2 
18 
 
10 
90 
 
16 
4 
 
80 
20 
Forix: 
a) Non-tender 
b) Tender 
 
20 
- 
 
100 
- 
 
- 
20 
 
- 
100 
 
13 
7 
 
65 
35 
 
Table 8: Showing changes in chief complaints and associated symptoms 
 
Leucorrhoea PID  DUB  Chief complaints 
  Before 
treatment 
After 
treatment 
Before 
treatment 
After 
treatment 
Before 
treatment  
After 
treatment
Vaginal discharge 
Itching in Vulva & 
Vagina 
Painful coitus 
Pain in Vulva & Vagina 
Pain of lower abdomen 
Pain during and befor 
menstruation 
Excessive bleeding  
Scanty bleeding 
Irregular menstruation 
Early menstruation 
Increased frequency of 
mictrurition 
Backache  
Loss of Appetite 
Burning feet syndrome 
Weal ness 
Palpitation  
 
20 
8 
 
8 
8 
5 
2 
 
- 
5 
2 
- 
5 
 
6 
5 
1 
1 
5 
2 
6 
 
0 
1 
2 
2 
 
- 
5 
0 
- 
2 
 
2 
0 
0 
0 
1 
 
20 
2 
 
18 
18 
20 
20 
 
5 
5 
10 
12 
15 
 
20 
10 
2 
2 
2 
 
4 
2 
 
9 
9 
15 
18 
 
2 
5 
4 
7 
5 
 
4 
0 
0 
0 
0 
5 
1 
 
2 
6 
5 
14 
 
18 
- 
4 
7 
2 
 
5 
10 
20 
20 
17 
0 
1 
 
0 
0 
10 
3 
 
4 
- 
0 
1 
0 
 
2 
0 
12 
14 
15 
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Table 9: Showing changes in hemoglobin (gm%) after treatment 
 
Leucorrhoea PID DUB  Chief complaints 
  Before 
treatment  
After 
treatment 
Before 
treatment 
After 
treatment 
Before 
treatment  
After 
treatment
8.0 
8.5 
9.0 
9.5 
10.0 
10.5 
11.0 
11.5 
12.0 
- 
- 
1 
5 
2 
3 
4 
3 
2 
- 
- 
0 
0 
1 
3 
5 
4 
7 
- 
1 
2 
4 
2 
3 
3 
2 
3 
- 
0 
0 
0 
1 
3 
7 
5 
4 
4 
4 
4 
5 
3 
- 
- 
- 
- 
0 
0 
2 
5 
6 
5 
2 
- 
- 
 
Table 10: Final outcome 
 
Severity of pain  Total  cases 
(n=60) 
No.(%) 
Leuco-rrhoea 
(n=20) No(%) 
PID 
(n=20) 
N0.(%) 
DUB 
(n=20) 
no(%) 
Cured 
 
Improved 
 
Partially improved 
 
Unchanged 
22(36.66) 
 
20(33.33) 
 
1.(16.67) 
 
8(13.33) 
14(70) 
 
3(15) 
 
1(5) 
 
2(10) 
2(10) 
 
9(45) 
 
5(25) 
 
4(20) 
6(30) 
 
8(40) 
 
4(20) 
 
2(10) 
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